Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Incyte Corporation - Common Stock (NQ:INCY)

92.59 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 92.59
Bid (Size) 92.10 (1)
Ask (Size) 95.00 (1)
Prev. Close 92.59
Today's Range 92.59 - 92.59
52wk Range 53.56 - 94.62
Shares Outstanding 222,430,635
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Incyte to Present at Upcoming Investor Conferences
From Incyte
Via Business Wire
INCY Q3 Deep Dive: Strong Product Momentum and Pipeline Reshaping Amid Strategic Refocus
Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 20% year on year to $1.37 billion. Its non-GAAP profit of... 
Via StockStory

Performance

YTD
+33.2%
+33.2%
1 Month
+9.2%
+9.2%
3 Month
+23.6%
+23.6%
6 Month
+49.3%
+49.3%
1 Year
+25.2%
+25.2%

More News

Read More
Incyte Delivers Robust Growth, But 2028 Patent Expiry Still Looms
Via Benzinga
Topics Intellectual Property
These S&P500 stocks have an unusual volume in today's session
Via Chartmill
Earnings Scheduled For October 28, 2025
Via Benzinga
Exploring Incyte's Earnings Expectations
Via Benzinga
Nasdaq 100 Hits 26,000, Gold Falls Below $4,000: What's Moving Markets Tuesday?
Via Benzinga
Topics Economy
Why Incyte (INCY) Stock Is Trading Lower Today
Via StockStory
Incyte (INCY) Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Incyte Falls After Hiked 2025 Outlook Misses Wall Street's Bullish Views
Via Investor's Business Daily
Topics Government
Incyte Corp (NASDAQ:INCY) Reports Strong Q3 2025 Earnings, Beating Estimates
Via Chartmill
Topics Earnings
Incyte (NASDAQ:INCY) Reports Strong Q3
Via StockStory
Topics Artificial Intelligence
Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates
From Incyte
Via Business Wire
Incyte and Enable Injections Announce Strategic Partnership for enFuse® On-Body Delivery System
From Incyte and Enable Injections
Via Business Wire
What To Expect From Incyte’s (INCY) Q3 Earnings
Via StockStory
Incyte Announces New Data from Phase 3b TRuE-AD4 Trial of Opzelura® (Ruxolitinib Cream) in Adults with Moderate Atopic Dermatitis
From Incyte
Via Business Wire
Eli Lilly's New Ebglyss Results Back Flexible Treatment Options For Atopic Dermatitis
Via Benzinga
INCYTE CORP (NASDAQ:INCY) Presents a Value Investing Opportunity with Strong Fundamentals
Via Chartmill
These S&P500 stocks are gapping in today's session
Via Chartmill
Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced Colorectal Cancer and KRAS G12D Inhibitor in Advanced Pancreatic Ductal Adenocarcinoma
From Incyte
Via Business Wire
Incyte (INCY) Stock Is Up, What You Need To Know
Via StockStory
Topics Artificial Intelligence
Incyte's (INCY) EVP and General Counsel Sold 4,100 Shares for $352,000
Via The Motley Fool
Topics Regulatory Compliance
Data from Incyte’s TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the European Society of Medical Oncology (ESMO) Congress 2025
From Incyte
Via Business Wire
JPMorgan Elevates Incyte Price Target Amidst Robust Pipeline and Commercial Success, Yet Maintains Cautious "Neutral" Stance
Via MarketMinute
Topics Economy Intellectual Property
What 14 Analyst Ratings Have To Say About Incyte
Via Benzinga

Frequently Asked Questions

Is Incyte Corporation - Common Stock publicly traded?
Yes, Incyte Corporation - Common Stock is publicly traded.
What exchange does Incyte Corporation - Common Stock trade on?
Incyte Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Incyte Corporation - Common Stock?
The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market
What is the current price of Incyte Corporation - Common Stock?
The current price of Incyte Corporation - Common Stock is 92.59
When was Incyte Corporation - Common Stock last traded?
The last trade of Incyte Corporation - Common Stock was at 10/30/25 04:00 PM ET
What is the market capitalization of Incyte Corporation - Common Stock?
The market capitalization of Incyte Corporation - Common Stock is 20.59B
How many shares of Incyte Corporation - Common Stock are outstanding?
Incyte Corporation - Common Stock has 21B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.